9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook (redirected fromECASS) Medical Acronyms Export Control Automated Support System Also called ECASS. A database of license information compiled and maintained by theBureau of Industry and Securityin the U.S. Departme...
European cooperative acute stroke study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: EXTEND. Int J Stroke. 2016; 11: 260-267.AMIRI H, BLUHMKI E, BENDSZUS M, et al. European cooperative acute stroke study-4: extending the time for thrombolysis in ...
患者被随机分为溶栓组 418例 或 InAcute 缺血性卒中试验 Desmoteplase安慰剂组 403例 ;实际治疗,溶栓组375例、 IschemicStroke Trial,DIAS “训104例患者安慰剂组355例。患者平均年龄65岁,男性分别 在3～9h内接受不同剂量去氨普酶的治疗,患占57%或63% 近2/3伴高血压、l5%伴糖尿病、 者NIHSS评分为4-20...
Impact of ECASS-3 trial publication on door-to-needle time in a stroke centerA.I., CallejaP., GarcíaBermejoN., TéllezE., RojoA.L., GuerreroJ., MarcoD., CamposN., FernándezBueyR., FernándezHerranzJ.F., Arenillas
Stroke treatment with alteplase given 3·0-4·5 h after onset of acute ischemic stroke (ES III): additional outcomes and subgroup analysis of a randomized controlled trial. Lancet Neurol. 2009; 8 :1095–102.Bluhmki E, Chamorro A, Dávalos A, Machnig T, Sauce C, Wahlgren N, et al. ...
Stingele R,,Bluhmki E,Hacke W.Bootstrap statistics of ECASS II data:just another post hoc analysis of anegative stroke trial.Cerebrovascular Diseases. 2001Stingele R, Bluhmki E, Hacke W. Bootstrap statistics of ECASS II data: just another post hoc analysis of a negative stroke trial?
Bootstrap statistics of ECASS II data: just another post hoc analysis of a negative stroke trial? Cerebrovascular Diseases. 2001;11:30 -33.Stingele R, Bluhmki E, Hacke W. Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial? Cerebrov...
Previous analysis of combined data from individual patients suggested potential benefit beyond 3 h from stroke onset. We re-examined the effect of time to treatment with intravenous rt-PA (alteplase) on therapeutic benefit and clinical risk by adding recent trial data to the analysis. We added ...
Previous analysis of combined data from individual patients suggested potential benefit beyond 3 h from stroke onset. We re-examined the effect of time to treatment with intravenous rt-PA (alteplase) on therapeutic benefit and clinical risk by adding recent trial data to the analysis. Methods We ...
1095-1102 - Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial - EM|consultedoi:10.1016/s1474-4422(09)70264-9Erich Bluhmki...